These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8952778)

  • 21. The efficacy of antenatal steroid therapy is dependent on the duration of low-concentration fetal exposure: evidence from a sheep model of pregnancy.
    Kemp MW; Saito M; Usuda H; Watanabe S; Sato S; Hanita T; Kumagai Y; Molloy TJ; Clarke M; Eddershaw PJ; Musk GC; Schmidt A; Ireland D; Furfaro L; Payne MS; Newnham JP; Jobe AH
    Am J Obstet Gynecol; 2018 Sep; 219(3):301.e1-301.e16. PubMed ID: 29758177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined hormonal treatment and lung maturation.
    Ballard PL
    Semin Perinatol; 1984 Oct; 8(4):283-92. PubMed ID: 6093266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic induction of fetal lung maturity.
    Roberts WE; Morrison JC
    Clin Obstet Gynecol; 1991 Jun; 34(2):319-27. PubMed ID: 1868639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal versus maternal and gestational age effects of repetitive antenatal glucocorticoids.
    Jobe AH; Newnham J; Willet K; Sly P; Ikegami M
    Pediatrics; 1998 Nov; 102(5):1116-25. PubMed ID: 9794943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of respiratory distress syndrome.
    Moya FR; Gross I
    Semin Perinatol; 1988 Oct; 12(4):348-58. PubMed ID: 3146813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung surfactant enhancement in utero.
    Di Renzo GC; Anceschi MM; Cosmi EV
    Eur J Obstet Gynecol Reprod Biol; 1989 Jul; 32(1):1-11. PubMed ID: 2670624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention and Treatment of Respiratory Distress Syndrome in Preterm Neonates.
    McPherson C; Wambach JA
    Neonatal Netw; 2018 May; 37(3):169-177. PubMed ID: 29789058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The status of prenatal lung ripening].
    Wolff F; Bolte A
    Geburtshilfe Frauenheilkd; 1990 Mar; 50(3):171-6. PubMed ID: 2187733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of hyaline membrane disease].
    Gerber A
    Monatsschr Kinderheilkd; 1986 Sep; 134(9):662-5. PubMed ID: 3785233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antenatal hormone therapy for fetal lung maturation.
    Merrill JD; Ballard RA
    Clin Perinatol; 1998 Dec; 25(4):983-97. PubMed ID: 9891625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fetal lung maturation and the antenatal use of glucocorticoids to prevent the respiratory distress syndrome.
    Shields JR; Resnik R
    Obstet Gynecol Surv; 1979 May; 34(5):343-63. PubMed ID: 379720
    [No Abstract]   [Full Text] [Related]  

  • 32. Surfactant in the perinatal period.
    Jobe AH
    Early Hum Dev; 1992; 29(1-3):57-62. PubMed ID: 1396280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidemiological survey of neonatal respiratory distress syndrome in part of northwest regions in China].
    Network of Northwest Neonatal Professional Collaboration Group
    Zhonghua Er Ke Za Zhi; 2015 May; 53(5):341-7. PubMed ID: 26080663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2003; (1):CD001146. PubMed ID: 12535402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant.
    Block MF; Kling OR; Crosby WM
    Obstet Gynecol; 1977 Aug; 50(2):186-90. PubMed ID: 327364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of corticosteroids for fetal maturation on perinatal outcomes.
    NIH Consens Statement; 1994 Feb 28-Mar 2; 12(2):1-24. PubMed ID: 7728157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Perinatal corticosteroid therapy: modalities, efficacy, consequences].
    Magny JF; Rigourd V; Kieffer F; Voyer M
    J Gynecol Obstet Biol Reprod (Paris); 2001 Feb; 30(1 Suppl):36-46. PubMed ID: 11240516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of antenatal steroids.
    Am J Obstet Gynecol; 1983 Dec; 147(7):851-52. PubMed ID: 6650620
    [No Abstract]   [Full Text] [Related]  

  • 40. Requirements of perinatal prevention and treatment of respiratory distress syndrome.
    Di Renzo GC; Anceschi MM; Guidetti R; Cosmi EV
    Eur Respir J Suppl; 1989 Mar; 3():68s-72s. PubMed ID: 2662998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.